K Number
K012939
Device Name
AEROVENT II CHC COLLAPSIBLE HOLDING CHAMBER
Date Cleared
2001-09-28

(28 days)

Product Code
Regulation Number
868.5630
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP Authorized
Intended Use
Collapsible Holding Chamber used as an accessory to administer meter dose inhalers to patients being mechanically ventilated.
Device Description
Not Found
More Information

Not Found

Not Found

No
The summary describes a simple mechanical device (collapsible holding chamber) and contains no mention of AI, ML, image processing, or data analysis that would suggest the use of such technologies.

No
The device is described as an "accessory to administer meter dose inhalers," indicating it facilitates the delivery of medication rather than directly providing a therapeutic effect itself.

No
Explanation: The device is described as a "Collapsible Holding Chamber used as an accessory to administer meter dose inhalers," which is for administering medication, not for diagnosing a condition.

No

The intended use describes a "Collapsible Holding Chamber," which is a physical hardware device used with inhalers. This is not a software-only device.

Based on the provided information, this device is not an IVD (In Vitro Diagnostic).

Here's why:

  • Intended Use: The intended use is to administer medication (meter dose inhalers) to patients. This is a therapeutic or drug delivery function, not a diagnostic one.
  • IVD Definition: In Vitro Diagnostics are devices used to examine specimens (like blood, urine, or tissue) taken from the human body to provide information for diagnosis, monitoring, or screening. This device does not interact with or analyze such specimens.

The device is an accessory for drug delivery in a specific patient population (mechanically ventilated).

N/A

Intended Use / Indications for Use

Collapsible Holding Chamber used as an accessory to administer meter dose medications to patients being mechanically ventilated.

Product codes

73 CAF

Device Description

Not Found

Mentions image processing

Not Found

Mentions AI, DNN, or ML

Not Found

Input Imaging Modality

Not Found

Anatomical Site

Not Found

Indicated Patient Age Range

Not Found

Intended User / Care Setting

Not Found

Description of the training set, sample size, data source, and annotation protocol

Not Found

Description of the test set, sample size, data source, and annotation protocol

Not Found

Summary of Performance Studies

Not Found

Key Metrics

Not Found

Predicate Device(s)

Not Found

Reference Device(s)

Not Found

Predetermined Change Control Plan (PCCP) - All Relevant Information

Not Found

§ 868.5630 Nebulizer.

(a)
Identification. A nebulizer is a device intended to spray liquids in aerosol form into gases that are delivered directly to the patient for breathing. Heated, ultrasonic, gas, venturi, and refillable nebulizers are included in this generic type of device.(b)
Classification. Class II (performance standards).

0

Image /page/0/Picture/1 description: The image is a black and white logo for the Department of Health & Human Services - USA. The logo features a stylized eagle with three lines forming its body and wings. The eagle is facing right. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" is arranged in a circular pattern around the eagle.

Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850

SEP 2 8 2001

Mr. James A. Cochie Monaghan Medical Corporation 5 Latour Avenue, Suite 1600 P.O. Box 2805 Plattsburgh, NY 12901-0299

Re: K012939

AeroVent IITM CHC Collapsible Holding Chamber Regulation Number: 868.5630 Regulation Name: Nebulizer Regulatory Class: II (two) Product Code: 73 CAF Dated: August 28, 2001 Received: August 31, 2001

Dear Mr. Cochie:

We have reviewed your Section 510(k) premarket notification of intent to market the device wt have teviewed your becamined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate for use stated in the enclosure) to regars from Medical Device Amendments, or to conninered phor to May 20, 2011 accordance with the provisions of the Federal Food, Drug, de vices mat nave been receasined in asse e approval of a premarket approval application (PMA). and Costicule Hor (110.) that to novice, subject to the general controls provisions of the Act. The Tournal controls provisions of the Act include requirements for annual registration, listing of general controll pro restice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it If your device is classified (600 as corrols. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean r lease oc acvised that I Drivision that your device complies with other requirements of the Act

1

or any Federal statutes and regulations administered by other Federal agencies. You must li or any Federal statutes and regulations administered by engistration and listing (21 l
comply with all the Act's requirements, including, but not limited to: registration and comply with all the Act Stequirements, mercesses cannons onectice requirements as set
CFR Part 807); labeling (21 CFR Part 801); good manufacturing as also destron CFK Part 807); labeling (21 CFR Part 800); government 820); and if applicable, the electronic
forth in the quality systems (QS) regulation (21 CFR Part 820); and if any 1000 forth in the quality systems (QD) regalentin (Sections 531-542 of the Act); 21 CFR 1000-1050.
Product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-

This letter will allow you to begin marketing your device as described in your Section 510(k) I his letter will anow you to begin manxemily of substantial equivalence of your device to a legally premarket nothleation. The FDA mailing of easification for your device and thus, permits your device to proceed to the market.

If you desire specific advice for your device on our labeling regulation (21 CFF) Part 801 and If you desire specific advice for your dovice of our the diagnostic devices), please contact the Office of additionally 21 CFK Patt 807.10 for m +120 the stimes on the promotion and advertising of
Compliance at (301) 594-4646. Additionally, for questions on the promotion and abe Compliance at (301) 594-4040. Additionally, to: quested (301) 594-4639. Also, please note the your device, prease connate the Office except to premarket notification' (21CFR Part 807.97).
regulation entitled, "Misbranding by reference to premarket notifical from the regulation entitled, "Misolanding by reference to printer the Act may be obtained from the Other general information on your responsional and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html

Sincerely yours,

Oelle Tleh

James E. Dillard III Director Division of Cardiovascular and Respiratory Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

2

Page 1 of 1 __

KO1Z939 510(k) Number (if known): ____________________________________________________________________________________________________________________________________________________

Device Name: _________________________________________________________________________________________________________________________________________________________________

Indications for Use:

Collapsible Holding Chamber used as an accessory to administer meter dose Oollapsible Trolung "Onatients being mechanically ventilated.

(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH, Office of Device Evaluation (ODE)

Division of Cardiovascular & Respiratory Devices
510(k) NumberK012939
Prescription Use (Per 21 CFR 801.109)
-------------------------------------------------------------------------------------------

or

Over-The-Counter Use
------------------------